Incyte (INCY) Short-term Investments (2010 - 2026)
Incyte (INCY) reported Short-term Investments of $554.7 million for Q1 2026, up 18.8% on a YoY basis from $466.9 million in Q1 2025, and up 14.9% quarter-over-quarter from $482.8 million in Q4 2025.
Incyte (INCY) Short-term Investments (2010 - 2026) Analysis & Trends
Incyte has reported Short-term Investments for 17 years, with the latest figure at $554.7 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments rose 18.8% year-over-year to $554.7 million; the trailing twelve-month figure through Mar 2026 stood at $554.7 million (up 18.8% YoY), and the FY2025 full-year result was $482.8 million, up 2.66% from the prior year.
- Short-term Investments for Q1 2026 stood at $554.7 million, up from $482.8 million in the prior quarter.
- The five-year high for Short-term Investments was $554.7 million in Q1 2026, with the low at $3.3 million in Q3 2024.
- Historically, Short-term Investments has averaged $373.6 million across 5 years, with a median of $442.7 million in 2023.
- Annual changes were most pronounced in 2024 — Short-term Investments plunged 98.84% — and 2025, when it soared 14098.98%.
- Incyte's Short-term Investments stood at $287.5 million in 2022, then soared by 53.95% to $442.7 million in 2023, then gained by 6.23% to $470.3 million in 2024, then climbed by 2.66% to $482.8 million in 2025, then advanced by 14.9% to $554.7 million in 2026.
- The last three Short-term Investments figures came in at $554.7 million (Q1 2026), $482.8 million (Q4 2025), and $474.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 554.71 Mn |
| Dec 31, 2025 | 482.79 Mn |
| Sep 30, 2025 | 474.81 Mn |
| Jun 30, 2025 | 466.77 Mn |
| Mar 31, 2025 | 466.94 Mn |
| Dec 31, 2024 | 470.26 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 462.21 Mn |
| Mar 31, 2024 | 504.48 Mn |
| Dec 31, 2023 | 442.67 Mn |
| Sep 30, 2023 | 289.22 Mn |
| Jun 30, 2023 | 292.24 Mn |
| Mar 31, 2023 | 291.66 Mn |
| Dec 31, 2022 | 287.54 Mn |
| Sep 30, 2022 | 286.50 Mn |
| Jun 30, 2022 | 287.04 Mn |
| Mar 31, 2022 | 287.40 Mn |
| Dec 31, 2021 | 290.75 Mn |
| Sep 30, 2021 | 285.05 Mn |
| Jun 30, 2021 | 283.39 Mn |